Children's Hospital, Geneva University Hospital
Geneva, Geneva 14, 1211, Switzerland
NCT Number: NCT02179398
Detecting serious bacterial infections (SBI) in children presenting to the Pediatric Emergency Department (PED) with fever without source (FWS) is a frequent diagnostic challenge. The recently described Lab-score, based on the combined determination of Procalcitonin, C-Reactive Protein (CRP) and urine dipstick results, has been shown an accurate tool for SBI prediction on retrospective cohorts. The investigators aimed to assess the usefulness of the Lab-score in safely decreasing unnecessary antibiotic prescriptions in children with FWS, and to prospectively determine the diagnostic characteristics of the Lab-score compared to other classically used SBI biomarkers (white blood cell (WBC) count, band count and CRP).
Looking for future studies?
Notify Me7 day–3 year
All sexes
Interventional
Not applicable
Geneva, Geneva 14, 1211, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at PED (Pediatric Emergency Department) presentation
Time frame: at 72 hours from PED presentation
Time frame: at PED presentation
Time frame: at 72 hours from PED presentation
Time frame: at 72 hours from PED presentation
Time frame: at 72 hours from PED presentation
Sensitivity of standard biological marker for SBI: WBC ≥ 15'000/mm³ and/or bands ≥ 1'500/mm³ and/or CRP ≥ 40 mg/L
Time frame: at 72 hours from PED presentation
Specificity of standard biological marker for SBI: WBC ≥ 15'000/mm³ and/or bands ≥ 1'500/mm³ and/or CRP ≥ 40 mg/L
University Hospital, Geneva
Other
Impact of the Lab-score on Antibiotic Prescription Rate in Children Aged 7 Days to 3 Years Old With Fever Without Source.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03607162
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Angers, France
View Trial DetailsNCT02025699
Bacteremia, Bacterial Infections
Hadera, Israel
View Trial DetailsNCT01917461
Digestive System Diseases, Fever Without Source
Hadera, Israel
View Trial DetailsNCT00692848
Bacteremia, Bacterial Infection
Montreal, Quebec, Canada
View Trial Details